Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

NCT02590367 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Neuropathy

Interventions

DRUG: FOLFOX regimen
DRUG: HD6610 Granule
DRUG: HD6610 Granule placebo

Sponsor

Jiangsu Province Hospital of Traditional Chinese Medicine